https://www.fda.gov/advisory-committees/endocrinologic-and-metabolic-drugs-advisory-committee/june-28-2016-meeting-endocrinologic-and-metabolic-drugs-advisory-committee
June 28, 2016: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee | FDA
The committee will discuss supplemental new drug application (sNDA) 204629 for empagliflozin (JARDIANCE) tablets and sNDA 206111 for empagliflozin and...